Summary
- Current Price
- As of today, FHTX price is $1.91, down -9.29% on
- Current Price All-Time High
- FHTX price is currently -93.26% below its historical high of $28.27 set on
- Market Cap
- FHTX current market cap is $113M, down -49.98% year-over-year
- Revenue
- FHTX current annual revenue is $30.91M, up +36.75% year-over-year
- Next Earnings
- The next earnings release for FHTX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Foghorn Therapeutics Inc. |
| Ticker | NASDAQ: FHTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | foghorntx.com |
| Employees | 112 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $1.91 | ||
| Price, 1D Change | -9.29% | |
| $113M | ||
| - | ||
| - | ||
| 1.50 | ||
| $30.91M | ||
| Revenue, 1Y Change | +36.75% | |
| -$1.18 | ||
| EPS, 1Y Change | +25.24% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.18 | ||
| EPS Estimate | -$0.93 | N/A |
| EPS Est. Change | +21.58% | N/A |
| $30.91M | ||
| Revenue Estimate | $28.71M | N/A |
| Revenue Est. Change | -7.10% | N/A |
| $1.91 | ||
| Price Target | $5.00 | - |
| Price Tgt. Change | +162.47% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.48 | -$1.58 | -6.61% | |
| -$1.08 | -$1.18 | -8.99% | |
| -$0.93 | N/A | +21.58% | |
| -$1.03 | N/A | +13.00% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $29.53M | $22.60M | -23.47% | |
| $31.22M | $30.91M | -1.00% | |
| $28.71M | N/A | -7.10% | |
| $6.43M | N/A | -79.18% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -52.38% | ||
| -50.26% | ||
| -49.98% | ||
| -30.03% | ||
| +36.75% | ||
| +60.75% | ||
| +25.24% | ||
| +54.94% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $1.91 | ||
| $4.63 | ||
| $3.22 | ||
| $4.30 | ||
| $3.02 | ||
| -$0.29 | ||
| 1.50 | ||
| $0.19 | ||
| 26.91 | ||
| 57.30% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $30.91M | ||
| -$1.18 | ||
| $27.58M | ||
| 89.22% | ||
| -$82.11M | ||
| -265.64% | ||
| -$74.28M | ||
| -240.33% | ||
| -$78.78M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| -0.38 | ||
| 2.73 | ||
| 2.73 | ||
| - | ||
| 3 | ||
| -2.40 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 3.08 | ||
| -1.40 | ||
| 0.17 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$108.50M | ||
| $160.14M | ||
| $394.66M | ||
| $163.24M | ||
| $503.16M | ||
| $59.74M | ||
| $41.27M | ||
| $923.00K | ||
| $4.27M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $105.19M | ||
| $109.68M | ||
| $3.33M | ||
| $0.00 | ||
| $3.33M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$86.10M | ||
| $112.04M | ||
| $1.02M | ||
| $50.00K | ||
| -$86.15M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wedbush | → | |
| TD Cowen | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| BTIG | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| Jefferies | → | |
| BTIG | ||
| Stifel |
Analyst sentiment
Institutional ownership
No data
Screeners with FHTX
FAQ
- What is the ticker symbol for Foghorn Therapeutics Inc.?
- The ticker symbol for Foghorn Therapeutics Inc. is NASDAQ:FHTX
- Does Foghorn Therapeutics Inc. pay dividends?
- No, Foghorn Therapeutics Inc. does not pay dividends
- What sector is Foghorn Therapeutics Inc. in?
- Foghorn Therapeutics Inc. is in the Healthcare sector
- What industry is Foghorn Therapeutics Inc. in?
- Foghorn Therapeutics Inc. is in the Biotechnology industry
- What country is Foghorn Therapeutics Inc. based in?
- Foghorn Therapeutics Inc. is headquartered in United States
- When did Foghorn Therapeutics Inc. go public?
- Foghorn Therapeutics Inc. initial public offering (IPO) was on October 23, 2020
- Is Foghorn Therapeutics Inc. in the S&P 500?
- No, Foghorn Therapeutics Inc. is not included in the S&P 500 index
- Is Foghorn Therapeutics Inc. in the NASDAQ 100?
- No, Foghorn Therapeutics Inc. is not included in the NASDAQ 100 index
- Is Foghorn Therapeutics Inc. in the Dow Jones?
- No, Foghorn Therapeutics Inc. is not included in the Dow Jones index
- When was Foghorn Therapeutics Inc. last earnings report?
- Foghorn Therapeutics Inc.'s most recent earnings report was on August 6, 2026
- When does Foghorn Therapeutics Inc. report earnings?
- The next expected earnings date for Foghorn Therapeutics Inc. is November 5, 2026
Data Sources & References
- FHTX Official Website foghorntx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1822462/000162828026016814/0001628280-26-016814-index.htm
- FHTX Profile on Yahoo Finance finance.yahoo.com/quote/FHTX
- FHTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/fhtx